Ozone therapy in pregravidar preparation for the application of assisted reproductive technology programs

Gur’eva V.A.; Kurguskina E.A.; Momot A.P.; Lebedeva E.I.

doi:https://doi.org/10.17116/rosakush20252505167

Gur’eva V.A.

Altai State Medical University

ORCID: 0000-0003-3901-2036

Kurguskina E.A.

Center for Public Health and Medical Prevention of Sochi

Momot A.P.

National Medical Research Center of Hematology Altai Branch

ORCID: 0000-0002-2708-1133

Lebedeva E.I.

Altai State Medical University

ORCID: 0000-0003-2988-5837

Ozone therapy in pregravidar preparation for the application of assisted reproductive technology programs

Authors:

Gur’eva V.A., Kurguskina E.A., Momot A.P., Lebedeva E.I.

More about the authors

Journal: Russian Bulletin of Obstetrician-Gynecologist. 2025;25(5): 67‑74

DOI: 10.17116/rosakush20252505167

Read: 194 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Gur’eva VA, Kurguskina EA, Momot AP, Lebedeva EI. Ozone therapy in pregravidar preparation for the application of assisted reproductive technology programs. Russian Bulletin of Obstetrician-Gynecologist. 2025;25(5):67‑74. (In Russ.)
https://doi.org/10.17116/rosakush20252505167

Подписка 2026 Российский вестник акушера-гинеколога (Russian Bulletin of Obstetrician-Gynecologist)

Использование инфографики авторами научных работ

Close metadata

OBJECTIVE

Evaluation of the effectiveness of the effects of low-dose ozone therapy on the morpho-functional state of the endometrium and the hemostasis system at the stage of preliminary preparation for the use of assisted reproductive technology (ART) programs.

MATERIALS AND METHODS

The study included 80 patients, 40 of whom made up the main group, who underwent a 7-day course of treatment with ozonated isotonic sodium chloride solution with a daily dose of 160 mcg/l as a preconceptive preparation before starting the ART program; the comparison group included 40 patients who did not receive preconceptive preparation in for various reasons. The morpho-functional state of the endometrium was assessed by three ultrasound parameters (M-echo, resistance index and maximum blood flow rate in the uterine arteries), by 5 luminescence spectroscopy indicators (indices of aerobicity, proliferation, microcirculation, the state of structure and metabolism of the endometrium). The hemostasis system was studied according to 11 criteria (platelet aggregation, prothrombin time, antithrombin III, activated partial thromboplastin time, D-dimer, international normalized ratio, plasminogen, protein C, prothrombin index, soluble fibrin-monomer complexes, fibrinogen).

RESULTS

Evidence of optimization of the morpho-functional state of the endometrium due to the antihypoxic and anticoagulant effects of ozone therapy with increased M-echo (p<0.0001) and maximum blood flow velocity (p<0.0001) in the uterine arteries, increased indices of aerobicity (p<0.0001), microcirculation (p<0.0001), regeneration (p<0.0001), optimization of the structure (p=0.035) and metabolism of the endometrium (p=0.021), hypocoagulation shifts of indicators of the hemostasis system, this led to an increase in the frequency of pregnancy in the first cycle of in vitro fertilization (IVF) after preconception preparation compared with this indicator in the control group.

CONCLUSION

Low-dose ozone therapy, performed as a preliminary preparation, improved the morpho-functional state of the endometrium, including its anticoagulant effect, which created favorable conditions for preimplantation endometrial remodeling in women with chronic endometritis, thereby increasing the frequency of pregnancy in the first IVF cycle.

Keywords:

preconception preparation

chronic endometritis

failures of in vitro fertilization

low-dose ozone therapy

luminescent spectroscopy

Authors:

Gur’eva V.A.

Altai State Medical University

ORCID: 0000-0003-3901-2036

Kurguskina E.A.

Center for Public Health and Medical Prevention of Sochi

Momot A.P.

National Medical Research Center of Hematology Altai Branch

ORCID: 0000-0002-2708-1133

Lebedeva E.I.

Altai State Medical University

ORCID: 0000-0003-2988-5837

Received:

24.11.2024

Accepted:

17.12.2024

Close metadata

References:

Kuz’mina TE, Pashkov VM, Klindukhov IA. Pregravid preparation. Modern concepts. Voprosy ginekologii, akusherstva i perinatologii. 2015;14:5:3-9. (In Russ.).
Ozodoeva IB, Petrov YuA, Sultygova LA. Preparation for programs of assisted reproductive technologies in chronic endometritis. Mezhdunarodnyi zhurnal prikladnykh i fundamental’nykh issledovanii. 2020;8:37-41. (In Russ.).
Medzhidova DR, Nurmagomedova SS, Omarov NSM. The use of medical ozone in the complex of pre-conception care of patients with recurrent miscarriages. Vestnik RUDN, ser. Meditsina. Akusherstvo i ginekologiya. 2011;6:34-38. (In Russ.).
Grishchenko NG, Kotlik YuA, Vesich TL, Kuz’mina OA. Optimization of the results of in vitro fertilization programs using exogenous nitric oxide to increase the receptivity of the endometrium. Tavricheskii mediko-biologicheskii vestnik. 2012;15:2:80-82. (In Russ.).
Danusevich IN, Kozlova LS, Suturina LV, Il’in VP, Beketova IS. Status of main components of immunity in women with reproductive disorders with chronic endometritis and in its absence. Bulleten’ of the East Siberian Scientific Center of the Academy of Medical Sciences. 2012;3:2:72-74. (In Russ.).
Murashko AV, Murashko AA. Anticoagulant therapy in using of assisted reproductive technologies. Doctor.ru. Ginekologiya. 2015; 11:112:12-16. (In Russ.).
Tabolova VK, Korneeva IE. The effect of chronic endometritis on the outcomes of assisted reproductive technology programs: morphofunctional and molecular genetic features. Akushertvo i ginekologiya. 2013;10:17-22. (In Russ.).
Leshchenko OYa. Chronic endometritis and reproductive disorders: versions and controversies. Bulleten’ sibirskoi meditsiny. 2020;19:3:166-176. (In Russ.). https://doi.org/10.20538/1682-0363-2020-3-166-176
Radzinskii VE, Petrov YuA, Kalinina EA, Shirokova DV, Polina MV. Pathogenetic features of macrotypes of chronic endometritis. Kazanskii meditsinskii zhurnal. 2017;98:1:27-34. (In Russ.). https://doi.org/10.17750/KMJ2017-27
Sukhikh GT, Shurshalina AV. Chronic endometritis. Management. Moscow: GEOTAR-Media. 2013;64. (In Russ.).
Papashiva EI, Konoplyannikov AG, Karaganova EYa. The importance of preconception care in improving the effectiveness of in vitro fertilization. Russian Bulletin of Obstetrician-Gynecologist. 2019;19:5:29-37. (In Russ.). https://doi.org/10.17116/rosakush20191905129
Savel’eva GM, Mikhalev SA, Konoplyannikov AG, Mikhaleva LM, Babichenko II, Boltovskaya MN. Chronic endometritis is an indication for preconception care. Clinical practice. 2018;9:2:36-41. (In Russ.).
Serebrennikova KG, Kuznetsova EP, Vanke ES, Ivanova TV, Miloslavskii YuV. Preconception care in patients with thin endometrium in assisted reproductive technology programs. Meditsinskie novosti. 2017;8:26-33. (In Russ.).
Bitsadze VO, Akin’shina SV, Andreeva MD, Makatsariya AD. Thromboembolic complications related to the use of assistive reproductive treatment. Ovarian hyperstimulation syndrome. Prakticheskaya meditsina. 2013;7:76:20-31. (In Russ.).
Chan WS, Dixon ME. The “ART” of thromboembolism: a review of assisted reproductive technology and thromboembolic complications. Thromb Res. 2008;121:6:713-726. https://doi.org/10.1016/j.thromres.2007.05.023
Kositskii IG. Human physiology. Moscow: Al’yans. 2015;544. (In Russ.).
Syundyukova EG, Medvedev BI, Sashenkov SL, Diner NM, Uzlova TV, Medvedev OM. Technology of ozone therapy in the prevention and treatment of obstetric pathology. Rossiiskii vestnik akushera-ginekologa. 2020;20:5:33-37. (In Russ.).
Klemente Apumaita KhM, Murashko AV, Sidorova IS, Pak SV, Grechkanev GO, Dvoryanskii SA, Iutinskii EM. Effect of ozonotherapy on blood coagulation state of patients with chronic placental insufficiency. Permskii meditsinskii zhurnal. 2010;27:1:57-61. (In Russ.).
Dudareva YuA, Gur’eva VA. Use of therapy ozone of periconceptional preparation in the program of rehabilititation of women with chronic endometritis. Lechashchii vrach. 2020;12:23:06-08. (In Russ.). https://doi.org/10.26295/OS.2020.55.19.001
Zemskov AM, Zemskov VM, Karaulov AV. Clinical immunology and allergology. Moscow: Infra-M. 2023;420. (In Russ.).
Zmyzgova AV, Maksimov VA. Clinical aspects of ozone therapy. Moscow. 2003;287. (In Russ.).
Rogolino A, Coccia ME, Fedi S, Gori AM, Cellai AP, Scarselli GF, Prisco D, Abbate R. Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome. Blood Coagul Fibrinolysis. 2003;14:3:277-282. https://doi.org/10.1097/01.mbc.0000061296.28953.d0